Comparative mRNA booster effectiveness against death or hospitalization with COVID-19 pneumonia across at-risk US Veteran populations

Studies of comparative mRNA booster effectiveness among high-risk populations can inform mRNA booster-specific guidelines. The study emulated a target trial of COVID-19 vaccinated U.S. Veterans who received three doses of either mRNA-1273 or BNT162b2 vaccines. Participants were followed for up to 32...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelly, J. Daniel, Leonard, Samuel, Boscardin, W. John, Hoggatt, Katherine J., Lum, Emily N., Austin, Charles C., Byers, Amy, Tien, Phyllis C., Austin, Peter C., Bravata, Dawn M., Keyhani, Salomeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205032/
https://www.ncbi.nlm.nih.gov/pubmed/37221198
http://dx.doi.org/10.1038/s41467-023-38503-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205032/
https://www.ncbi.nlm.nih.gov/pubmed/37221198
http://dx.doi.org/10.1038/s41467-023-38503-8

Ejemplares similares